aztreonam and d13-9001

aztreonam has been researched along with d13-9001 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hoshino, K; Imamura, Y; Kanda, H; Kuru, N; Lee, VJ; Nakayama, K; Namba, K; Nitanai, H; Ohtsuka, M; Sakamoto, A; Takemura, M; Watkins, WJ; Yokomizo, Y; Yoshida, K; Zhang, JZ	1

Other Studies

1 other study(ies) available for aztreonam and d13-9001

Article	Year
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate. Bioorganic & medicinal chemistry, 2007, Nov-15, Volume: 15, Issue:22 Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Female; Haplorhini; Infusions, Intravenous; Male; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Pseudomonas aeruginosa; Pseudomonas Infections; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Solubility; Stereoisomerism	2007

Article

Year

MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate.

Bioorganic & medicinal chemistry, 2007, Nov-15, Volume: 15, Issue:22

Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Female; Haplorhini; Infusions, Intravenous; Male; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Pseudomonas aeruginosa; Pseudomonas Infections; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Solubility; Stereoisomerism

2007